(Press-News.org) Can artificial intelligence (AI) help reduce deaths in hospital? An AI-based system was able to reduce risk of unexpected deaths by identifying hospitalized patients at high risk of deteriorating health, found new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.240132.
Rapid deterioration among hospitalized patients is the primary cause of unplanned admission to the intensive care unit (ICU). Previous research has attempted to use technology to identify these patients, but evidence is mixed about the application of prediction tools to help vulnerable patients at highest risk.
Researchers from Unity Health Toronto, ICES, and the University of Toronto studied the effectiveness of CHARTWatch, an AI-based early warning system used on the general internal medicine (GIM) ward at St. Michael’s Hospital after 3 years of development and testing.
The study included 13 649 patients aged 55–80 years admitted to GIM (9626 in the pre-intervention period and 4023 using CHARTWatch) and 8470 admitted to subspeciality units that did not use CHARTWatch. During the 19-month-long intervention period, 482 patients in GIM became high-risk, compared with 1656 patients who became high risk in the 43-month-long pre-intervention period. There were fewer nonpalliative deaths in the CHARTWatch group than in the pre-intervention group (1.6% v. 2.1%).
"As AI tools are increasingly being used in medicine, it is important that they are evaluated carefully to ensure that they are safe and effective,” says lead author Dr. Amol Verma, a clinician-scientist at St. Michael’s Hospital, Unity Health Toronto, and Temerty professor of AI research and education in medicine, University of Toronto, Toronto, Ontario. “Our findings suggest that AI-based early warning systems are promising for reducing unexpected deaths in hospitals."
Regular communications helped reduce deaths as CHARTWatch engaged clinicians with real-time alerts, twice-daily emails to nursing teams, and daily emails to the palliative care team. The team also created a care pathway for high-risk patients with increased monitoring by nurses, enhanced communication between nurses and physicians, and prompts to encourage physicians to reassess patients.
“Ultimately, this study shows how AI systems can support nurses and doctors in providing high-quality care,” says Dr. Verma.
The authors hope that AI solutions like CHARTWatch can improve patient health and avoid premature deaths.
“This important study evaluates the outcomes associated with the complex deployment of the entire AI solution, which is critical to understanding the real-world impacts of this promising technology,” says coauthor Dr. Muhammad Mamdani, vice president of data science and advanced analytics at Unity Health Toronto and director of the University of Toronto Temerty Faculty of Medicine Centre for AI Research and Education in Medicine. “We hope other institutions can learn from and improve upon Unity Health Toronto’s experiences to benefit the patients they serve. Unity Health Toronto is a collaborative leader already helping to spread our AI tools via innovative partnerships with more to come.”
A second article https://www.cmaj.ca/lookup/doi/10.1503/cmaj.240363 provides a snapshot of what physicians should know if they are thinking of using AI scribes in clinical practice, including the importance of obtaining patient consent, reviewing AI-generated notes for errors, and ensuring the software complies with local privacy legislation.
END
AI-based tool reduces risk of death in hospitalized patients
2024-09-16
ELSE PRESS RELEASES FROM THIS DATE:
Replacing ultra-processed foods in diet reduces type 2 diabetes risk
2024-09-15
People who eat more ultra-processed foods (UPF) are at increased risk of developing type 2 diabetes, but this risk can be lowered by consuming less processed foods instead, finds a new study led by researchers at UCL.
The study, published in The Lancet Regional Health – Europe in collaboration with experts at the University of Cambridge and Imperial College London, investigated the relationship between the degree of food processing and type 2 diabetes risk, including which kinds of UPF were most high-risk.
The team analysed UPF intake and health outcomes for 311,892 individuals from eight European countries over 10.9 years on average, during which time 14,236 people developed type 2 ...
High-Dose vitamin D3 does not provide benefit for metastatic colorectal cancer
2024-09-15
RESEARCH SUMMARY
Study Title: SOLARIS (Alliance A021703): A multicenter double-blind phase III randomized clinical trial of vitamin D combined with standard chemotherapy plus bevacizumab in patients with previously untreated metastatic colorectal cancer.
Publication: European Society for Medical Oncology 2024 Abstract LBA26
Dana-Farber Cancer Institute authors: Kimmie Ng, MD, MPH, Nadine McCleary, MD, MPH, Jeffrey A. Meyerhardt, MD, MPH
Summary: A double-blind randomized phase 3 clinical trial led by Dana-Farber Cancer Institute researchers and conducted across several hundred cancer centers in the U.S. tested the addition of high-dose ...
Long-term metastatic melanoma survival dramatically improves on immunotherapy
2024-09-15
Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a new report from Weill Cornell Medicine and Dana-Farber Cancer Center investigators and their colleagues.
The 10-year follow-up study, published Sept. 15 in the New England Journal of Medicine, will bring the phase 3 CheckMate 067 trial to a close. The trial, which followed 945 patients treated at 137 sites in 21 countries, demonstrated that combining ...
Contrail avoidance is less likely to damage climate by mistake than previously thought
2024-09-15
A new study allays fears that rerouting flights to avoid forming climate-warming contrails could result in inadvertently making climate warming worse.
Researchers from Sorbonne Universite and the University of Reading found that for most flights that form contrails in the North Atlantic, the climate benefit of avoiding the contrail outweighs the extra carbon dioxide emitted from flying a different route.
Contrail avoidance requires comparing the climate impacts of carbon dioxide and contrails, called CO2 equivalence. Different methods have been proposed, and the choice of which has been largely political. Scientists feared that some choices ...
Breast cancer research: New studies show how post-treatment lifestyle choices shape long-term outcomes after diagnosis
2024-09-15
Young patients can safely breastfeed without increasing the risk of cancer recurrence or new cancer in the opposite breast
Telephone-based intervention can successfully prompt patients who are overweight to exercise more, lowering their weight
BARCELONA, SPAIN – Three studies led by Dana-Farber Cancer Institute researchers have encouraging implications for patients with breast cancer. Two studies focus on breastfeeding after breast cancer diagnosis and treatment. The studies found it was safe and feasible for young patients carrying specific genetic variations to breastfeed without raising their risk of a cancer recurrence or a cancer in the other breast, and that it was safe ...
New meta-analysis shows that hormone therapy can significantly reduce insulin resistance
2024-09-14
CLEVELAND, Ohio (Sept 10, 2024) –Menopausal women are at greater risk of insulin resistance as a result of declining estrogen levels. Previous studies evaluating the potential benefits of hormone therapy on insulin resistance have produced mixed results. However, a new meta-analysis of 17 different randomized, controlled trials suggests hormone therapy can be beneficial. Results of the meta-analysis will be presented at the 2024 Annual Meeting of The Menopause Society in Chicago September 10-14.
Insulin resistance can occur in men or women, but menopausal women are at ...
Genomics reveals sled dogs’ Siberian lineage
2024-09-14
ITHACA, N.Y. – New research co-led by Cornell University examines thousands of years of Arctic sled dog ancestry and reveals when and how Siberian and Alaskan sled dogs’ DNA mixed.
“There was a real concern from Siberian breeders – who were mostly racing their dogs – that they were sending out their dogs’ DNA samples for analysis, more for the context of health traits, and they were getting breed ancestry information back that said their dog was not 100% Siberian husky,” said Heather Huson, a former ...
ESMO: Combination therapy reduced agitated delirium in patients with advanced cancers
2024-09-14
ABSTRACT: 1476O
BARCELONA, Spain ― Treatment with a combination of haloperidol and lorazepam reduced symptoms of agitated delirium, a common end-of-life condition for patients with advanced cancers, compared with haloperidol alone, according to a new study led by researchers at The University of Texas MD Anderson Cancer Center. The findings were presented today at the 2024 European Society for Medical Oncology (ESMO) Congress.
Agitated delirium occurs when a patient’s brain function begins to deteriorate as their cancer advances, resulting in many patients beginning to behave aggressively or abnormally. Although the use of medication ...
SOPHiA GENETICS presents ground-breaking multimodal research on AI-driven patient stratification at ESMO 2024
2024-09-14
Boston, MA and Rolle, Switzerland, September 14, 2024 – SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a leader in data-driven medicine, will unveil new research at the European Society for Medical Oncology (ESMO) 2024. The study, conducted in collaboration with AstraZeneca, leverages advanced AI-driven techniques to identify subgroups of stage IV non-small cell lung cancer (NSCLC) patients who could most benefit from the addition of tremelimumab to durvalumab and chemotherapy.
The research is a retrospective, multimodal analysis of the POSEIDON Phase 3 clinical trial (NCT03164616). This trial originally demonstrated that the combination of tremelimumab, ...
Mitochondria at the crossroads of cholestatic liver injury: Targeting novel therapeutic avenues
2024-09-14
Bile acids are essential signaling molecules derived from cholesterol metabolism in the liver and are crucial for the digestion and absorption of fats. These molecules undergo further modification in the intestines by the gut microbiome. However, disruptions in bile flow, a condition known as cholestasis, can lead to the pathological accumulation of hydrophobic BAs in the liver and bloodstream. This accumulation not only exacerbates liver damage but also induces significant disturbances in cellular processes. The review focuses on recent developments in understanding how BAs contribute to liver injury by affecting mitochondrial function, endoplasmic reticulum ...